Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trials.
<h4>Background</h4>Amifostine is the most clinical used chemical radioprotector, but its effect in patients treated with radiation is not consistent.<h4>Methods</h4>By searching Medline, CENTRAL, EMBASE, ASCO, ESMO, and CNKI databases, the published randomized controlled tria...
Saved in:
| Main Authors: | Jundong Gu, Siwei Zhu, Xuebing Li, Hua Wu, Yang Li, Feng Hua |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0095968 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective Effects of Dexmedetomidine and Amifostine Against Radiotherapy-Induced Kidney Injury
by: Sule Batcik, et al.
Published: (2025-05-01) -
A meta-analysis of the relationship between RARβ gene promoter methylation and non-small cell lung cancer.
by: Feng Hua, et al.
Published: (2014-01-01) -
Radiotherapy improves the clinical outcomes of recurrent or metastatic head and neck cancers treated with immunotherapy
by: Yanshuang Cheng, et al.
Published: (2025-06-01) -
Hypofractionated versus conventional radiotherapy for head-and-neck cancer: A systematic review and meta-analysis
by: Arnab Roy, et al.
Published: (2025-01-01) -
Ocular Complications of Radiotherapy for Head and Neck Tumours
by: Sarita Maharia, et al.
Published: (2019-01-01)